Literature DB >> 3315634

Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16K forms.

C Clapp1.   

Abstract

A cleaved form of PRL (CPRL) has been reported to exist naturally in the pituitary and to be the main product of PRL proteolysis by its target tissues. A 16K fragment derived from CPRL has mammary mitogenic activity. To analyze the possible functional significance of the cleavage of PRL generated by incubation of unlabeled rat (r) PRL with a 25,000 generated by incubation of unlabeled rat (r) PRL with a 25,000 x g pellet from the mammary gland and liver of rats. The optimum pH for cleavage was 3.4. PRL and the cleaved products were easily identified and separated from other proteins in the sample. The mammary gland pellet from lactating rats was significantly more potent at cleaving the rPRL molecule than were those of virgin or pregnant rats. However, the livers of all rats showed a similar PRL-cleaving potency. Thus, target tissues may differ in their PRL-cleaving potencies in different physiological states. The PRL-cleaving activity was also present in rat milk. While cleaved and 16K PRLs were the only proteolytic products obtained from rPRL, the PRLs (ovine and human) or the GHs (rat, bovine, and human) of other species were processed into a variety of low mol wt forms. Human placental lactogen was not modified. Accordingly, the processing of rPRL by target tissue enzymes appears to be hormone and species specific. Cleaved and 16K PRLs had 100% and 6.5% of the binding activity for rat liver PRL receptors as did intact rPRL, respectively. Nevertheless, the 16K form may still be of physiological significance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315634     DOI: 10.1210/endo-121-6-2055

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Authors:  I Struman; F Bentzien; H Lee; V Mainfroid; G D'Angelo; V Goffin; R I Weiner; J A Martial
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 2.  Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions.

Authors:  Robert J Marano; Nira Ben-Jonathan
Journal:  Mol Endocrinol       Date:  2014-04-02

3.  Characterization of a bioactive 15 kDa fragment produced by proteolytic cleavage of chicken growth hormone.

Authors:  C Arámburo; M Carranza; M Reyes; M Luna; H Martinez-Coria; L Berúmen; C G Scanes
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

4.  Inhibitory activity of the peptides derived from buffalo prolactin on angiogenesis.

Authors:  Jaeok Lee; Syamantak Majumder; Suvro Chatterjee; Kambadur Muralidhar
Journal:  J Biosci       Date:  2011-06       Impact factor: 1.826

5.  16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo.

Authors:  J M Faupel-Badger; E Ginsburg; J M Fleming; L Susser; T Doucet; B K Vonderhaar
Journal:  Horm Cancer       Date:  2010-04       Impact factor: 3.869

6.  Prolactin and 16K prolactin stimulate release of vasopressin by a direct effect on hypothalamo-neurohypophyseal system.

Authors:  Salvador Mejía; Luz M Torner; Michael C Jeziorski; Carmen Gonzalez; Miguel A Morales; Gonzalo Martín de la Escalera; Carmen Clapp
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

Review 7.  Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland.

Authors:  Carmen Clapp; Stéphanie Thebault; Gonzalo Martínez de la Escalera
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

8.  The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin.

Authors:  C Clapp; L Torner; G Gutiérrez-Ospina; E Alcántara; F J López-Gómez; M Nagano; P A Kelly; S Mejía; M A Morales; G Martínez de la Escalera
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation.

Authors:  Celina García; Jorge Aranda; Edith Arnold; Stéphanie Thébault; Yazmín Macotela; Fernando López-Casillas; Valentín Mendoza; Hugo Quiroz-Mercado; Hebert Luis Hernández-Montiel; Sue-Hwa Lin; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

10.  Isolation of cleaved prolactin variants that stimulate DNA synthesis in specific cell types in rat pituitary cell aggregates in culture.

Authors:  M Andries; D Tilemans; C Denef
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.